BBR Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-82,000
Closed -$16.4M 230
2021
Q2
$16.4M Sell
82,000
-38,221
-32% -$7.41M 1.29% 9
2021
Q1
$23.4M Hold
120,221
1.92% 6
2020
Q4
$23M Sell
120,221
-26,000
-18% -$4.73M 1.91% 6
2020
Q3
$21.6M Buy
+146,221
New +$20.9M 1.85% 6

Other funds holding RGEN

BBR Partners's RGEN Position: Q3 2021 in Review

BBR Partners sold out of Repligen (RGEN) in Q3 2021, closing a stake of 82,000 shares — an estimated $16.4M sold.

BBR Partners first reported a position in RGEN in Q3 2020 and held it in 4 quarters. The position peaked at $23.4M in Q1 2021. 478 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.

  • BBR Partners reported no remaining Repligen position as of Q3 2021 after selling out during the quarter.
  • BBR Partners sold 82,000 Repligen shares in Q3 2021, an estimated $16.4M.
  • BBR Partners first reported a position in Repligen in Q3 2020 and held it in 4 quarters.
  • BBR Partners's Repligen position peaked at $23.4M in Q1 2021.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q3 2021.

Based on BBR Partners's 13F filing for Q3 2021, filed 12 Nov 2021.